Literature DB >> 19477432

Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.

Shuying Liu1, Makiko Umezu-Goto, Mandi Murph, Yiling Lu, Wenbin Liu, Fan Zhang, Shuangxing Yu, L Clifton Stephens, Xiaojiang Cui, George Murrow, Kevin Coombes, William Muller, Mien-Chie Hung, Charles M Perou, Adrian V Lee, Xianjun Fang, Gordon B Mills.   

Abstract

Lysophosphatidic acid (LPA) acts through high-affinity G protein-coupled receptors to mediate a plethora of physiological and pathological activities associated with tumorigenesis. LPA receptors and autotaxin (ATX/LysoPLD), the primary enzyme producing LPA, are aberrantly expressed in multiple cancer lineages. However, the role of ATX and LPA receptors in the initiation and progression of breast cancer has not been evaluated. We demonstrate that expression of ATX or each edg family LPA receptor in mammary epithelium of transgenic mice is sufficient to induce a high frequency of late-onset, estrogen receptor (ER)-positive, invasive, and metastatic mammary cancer. Thus, ATX and LPA receptors can contribute to the initiation and progression of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477432      PMCID: PMC4157573          DOI: 10.1016/j.ccr.2009.03.027

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  60 in total

1.  Persistent E-cadherin expression in inflammatory breast cancer.

Authors:  C G Kleer; K L van Golen; T Braun; S D Merajver
Journal:  Mod Pathol       Date:  2001-05       Impact factor: 7.842

2.  Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.

Authors:  Christine Desmedt; Fanny Piette; Sherene Loi; Yixin Wang; Françoise Lallemand; Benjamin Haibe-Kains; Giuseppe Viale; Mauro Delorenzi; Yi Zhang; Mahasti Saghatchian d'Assignies; Jonas Bergh; Rosette Lidereau; Paul Ellis; Adrian L Harris; Jan G M Klijn; John A Foekens; Fatima Cardoso; Martine J Piccart; Marc Buyse; Christos Sotiriou
Journal:  Clin Cancer Res       Date:  2007-06-01       Impact factor: 12.531

3.  Non-parametric quantification of protein lysate arrays.

Authors:  Jianhua Hu; Xuming He; Keith A Baggerly; Kevin R Coombes; Bryan T J Hennessy; Gordon B Mills
Journal:  Bioinformatics       Date:  2007-06-28       Impact factor: 6.937

4.  Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.

Authors:  Qing Zhang; Neil E Bhola; Vivian Wai Yan Lui; Doris R Siwak; Sufi M Thomas; Christopher T Gubish; Jill M Siegfried; Gordon B Mills; Dong Shin; Jennifer Rubin Grandis
Journal:  Mol Cancer Ther       Date:  2007-04       Impact factor: 6.261

Review 5.  Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.

Authors:  X Fang; D Gaudette; T Furui; M Mao; V Estrella; A Eder; T Pustilnik; T Sasagawa; R Lapushin; S Yu; R B Jaffe; J R Wiener; J R Erickson; G B Mills
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 6.  Living with p53, dying of p53.

Authors:  Yael Aylon; Moshe Oren
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

7.  An atomic model of the interferon-beta enhanceosome.

Authors:  Daniel Panne; Tom Maniatis; Stephen C Harrison
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

8.  Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation.

Authors:  Devang N Patel; Carter A King; Steven R Bailey; Jeffrey W Holt; Kaliyamurthi Venkatachalam; Alok Agrawal; Anthony J Valente; Bysani Chandrasekar
Journal:  J Biol Chem       Date:  2007-07-25       Impact factor: 5.157

9.  Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.

Authors:  Veronica C Estrella; Astrid M Eder; Shuying Liu; Terri B Pustilnik; Fazal H Tabassam; Francois X Claret; Gary E Gallick; Gordon B Mills; Jon R Wiener
Journal:  Int J Oncol       Date:  2007-08       Impact factor: 5.650

10.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  196 in total

1.  Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer.

Authors:  Shuying Liu; Shunqiang Li; Bailiang Wang; Wenbin Liu; Mihai Gagea; Huiqin Chen; Joohyuk Sohn; Napa Parinyanitikul; Tina Primeau; Kim-Anh Do; George F Vande Woude; John Mendelsohn; Naoto T Ueno; Gordon B Mills; Debu Tripathy; Ana M Gonzalez-Angulo
Journal:  Mol Cancer Ther       Date:  2018-12-05       Impact factor: 6.261

2.  Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.

Authors:  Abir Mukherjee; Jinhua Wu; Suzanne Barbour; Xianjun Fang
Journal:  J Biol Chem       Date:  2012-06-03       Impact factor: 5.157

Review 3.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

4.  The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.

Authors:  Songbai Lin; Sei-Jung Lee; Hyunsuk Shim; Jerold Chun; C Chris Yun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

5.  Location, location, location: a crystal-clear view of autotaxin saturating LPA receptors.

Authors:  Adel Tabchy; Gabor Tigyi; Gordon B Mills
Journal:  Nat Struct Mol Biol       Date:  2011-02       Impact factor: 15.369

Review 6.  How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.

Authors:  Matthew R Swiatnicki; Eran R Andrechek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-21       Impact factor: 2.673

7.  Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.

Authors:  David Luyimbazi; Argun Akcakanat; Priscilla F McAuliffe; Li Zhang; Gopal Singh; Ana Maria Gonzalez-Angulo; Huiqin Chen; Kim-Anh Do; Yuhuan Zheng; Mien-Chie Hung; Gordon B Mills; Funda Meric-Bernstam
Journal:  Mol Cancer Ther       Date:  2010-09-28       Impact factor: 6.261

8.  Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p.

Authors:  Sudeepti S Kuppa; Wei Jia; Shuying Liu; Ha Nguyen; Susan S Smyth; Gordon B Mills; Kevin K Dobbin; William J Hardman; Mandi M Murph
Journal:  Cancer Lett       Date:  2018-05-31       Impact factor: 8.679

9.  Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.

Authors:  Chaoyang Sun; Yong Fang; Jun Yin; Jian Chen; Zhenlin Ju; Dong Zhang; Xiaohua Chen; Christopher P Vellano; Kang Jin Jeong; Patrick Kwok-Shing Ng; Agda Karina B Eterovic; Neil H Bhola; Yiling Lu; Shannon N Westin; Jennifer R Grandis; Shiaw-Yih Lin; Kenneth L Scott; Guang Peng; Joan Brugge; Gordon B Mills
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

10.  An in vivo screening system to identify tumorigenic genes.

Authors:  T Ihara; Y Hosokawa; K Kumazawa; K Ishikawa; J Fujimoto; M Yamamoto; T Muramkami; N Goshima; E Ito; S Watanabe; K Semba
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.